Back to Authors

Guo, Kai

A5138386883 | I1330342723

Mayo Clinic

Citations 2

Tocilizumab and Satralizumab in MOGAD: Real-world Outcomes for Relapse Prevention (P3-1.002)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000216861

Expanding the Phenotype of MOGAD: Multiple Cranial Neuropathies in a Patient with Seronegative-CSF-positive MOG IgG (P7-1.010)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000216382